ATRS
Antares Pharma, Inc.
ATRS
ATRS
Delisted
ATRS was delisted on the 23rd of May, 2022.
135 hedge funds and large institutions have $204M invested in Antares Pharma, Inc. in 2019 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 40 increasing their positions, 34 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
61% less call options, than puts
Call options by funds: $908K | Put options by funds: $2.3M
Holders
135
Holding in Top 10
1
Calls
$908K
Puts
$2.3M
Top Buyers
| 1 | +$6.77M | |
| 2 | +$2.55M | |
| 3 | +$1.49M | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$1.45M |
| 5 |
MFAM
Motley Fool Asset Management
Alexandria,
Virginia
|
+$1.32M |
Top Sellers
| 1 | -$2.6M | |
| 2 | -$2.57M | |
| 3 | -$2.45M | |
| 4 |
Allianz Asset Management
Munich,
Germany
|
-$1.54M |
| 5 |
BC
Broadfin Capital
New York
|
-$1.36M |